IRIS
Del Re, Marzia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 512
SA - Sud America 321
NA - Nord America 181
EU - Europa 105
AF - Africa 19
Totale 1.138
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 333
BR - Brasile 295
US - Stati Uniti d'America 145
HK - Hong Kong 70
IT - Italia 55
MX - Messico 24
BD - Bangladesh 19
CN - Cina 17
IQ - Iraq 16
GB - Regno Unito 15
VN - Vietnam 14
IN - India 11
AR - Argentina 7
CO - Colombia 7
NL - Olanda 7
TR - Turchia 7
UA - Ucraina 7
DE - Germania 6
ZA - Sudafrica 6
CA - Canada 5
SA - Arabia Saudita 5
ES - Italia 4
TN - Tunisia 4
VE - Venezuela 4
EC - Ecuador 3
FR - Francia 3
KE - Kenya 3
RU - Federazione Russa 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BO - Bolivia 2
JO - Giordania 2
LB - Libano 2
NO - Norvegia 2
NP - Nepal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
MA - Marocco 1
MY - Malesia 1
OM - Oman 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SE - Svezia 1
SV - El Salvador 1
UG - Uganda 1
Totale 1.138
Salva come PNG Salva come JPEG
Città #
Singapore 230
Hong Kong 63
Rome 34
Mexico City 19
São Paulo 16
Milan 12
Beijing 9
Rio de Janeiro 9
Ribeirão Preto 7
Brasília 6
Dhaka 6
Santa Clara 6
Belo Horizonte 4
Guarulhos 4
Hanoi 4
Ho Chi Minh City 4
São José dos Campos 4
Vitória da Conquista 4
Ashburn 3
Atlanta 3
Campinas 3
Canoas 3
Ceres 3
Erbil 3
Fortaleza 3
Houston 3
Nairobi 3
Natal 3
Quận Mười 3
Rondonópolis 3
San Antonio 3
Tashkent 3
Tunis 3
Amman 2
Anápolis 2
Araraquara 2
Baghdad 2
Baku 2
Baltimore 2
Bogotá 2
Boston 2
Campo Largo 2
Campo Novo do Parecis 2
Cape Town 2
Caracas 2
Caraguatatuba 2
Cleveland 2
Curitiba 2
Dammam 2
Duque de Caxias 2
El Paso 2
Governador Valadares 2
Greenville 2
Iapu 2
Istanbul 2
Itajaí 2
Jacksonville 2
Jaipur 2
Juazeiro do Norte 2
Kathmandu 2
La Paz 2
Las Vegas 2
Macau 2
Maceió 2
Magé 2
Montevideo 2
Mosul 2
Najaf 2
New York 2
Niterói 2
Ourinhos 2
Passo Fundo 2
Paulo Afonso 2
Pelotas 2
Petrópolis 2
Porto Alegre 2
Poços de Caldas 2
Presidente Prudente 2
Pune 2
Raul Soares 2
Rio das Pedras 2
Riyadh 2
Salvador 2
Santa Cruz do Capibaribe 2
Santo André 2
Spring Valley 2
St Louis 2
Sulaymaniyah 2
Taubaté 2
Teresópolis 2
The Bronx 2
Tianjin 2
Verona 2
10th of Ramadan City 1
Ad Dīwānīyah 1
Addis Ababa 1
Ambato 1
Americana 1
Angra dos Reis 1
Antalya 1
Totale 613
Salva come PNG Salva come JPEG
Nome #
EGFR signaling pathway as therapeutic target in human cancers 18
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 15
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients 15
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 14
Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer 14
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series 13
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated Acute Myeloid Leukemia (AML) to guide treatment strategy 12
Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors 12
Updates on liquid biopsy: Current trends and future perspectives for clinical application in solid tumors 12
Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: A systematic review protocol 11
The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma 11
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib 11
ANKRd44 gene silencing: A putative role in trastuzumab resistance in HER2-like breast cancer 11
Recommendations for using molecular assays on liquid biopsy: the first document provided by intersociety Group AIOM, SIF, SIAPEC-IAP, SIBioC | Raccomandazioni per l’esecuzione di indagini molecolari su biopsia liquida in oncologia 11
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 11
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis 11
Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low-grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis? 10
Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs 10
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 10
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences 10
Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data 10
The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies 10
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 10
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics 10
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 10
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes 10
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 10
Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation 9
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 9
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years 9
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 9
Predicting Fluoropyrimidine-Related Toxicity: Turning Wish to Will, The Pamm-Eortc Position 9
Genome Wide Association Studies (GWAS) 9
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival 9
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment 9
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer 9
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST) 9
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 9
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial 9
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 9
Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting 9
Matching BRCA and prostate cancer in a public health system: Report of the Italian Society for Uro-Oncology (SIUrO) consensus project 9
Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice 9
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 9
Cross-Linked Hyaluronic Acid as Tear Film Substitute 9
Monitoring of secondary drug resistance mutations in circulating tumor DNA of patients with advanced ALK positive NSCLC 9
Should CYP2D6 be genotyped when treating with tamoxifen? 9
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial 9
Pharmacogenetic foundations of therapeutic efficacy and adverse events of statins 8
Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA 8
Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy 8
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view 8
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 8
Results of a comprehensive pharmacogenetic analysis of dihydropyrimidine dehydrogenase in patients treated with fluoropyrimidines and patterns of polymorphisms partially related to treatment tolerability 8
KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA 8
What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA 8
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer 8
Facing an un-met need in lung cancer screening: The never smokers 8
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives 8
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 8
DPYD IVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis 8
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 8
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 8
Empower the potential of trastuzumab deruxtecan with novel combinations 8
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer 8
Droplet digital PCR represents a new sensitive method for detecting B-RAFV600E mutation at diagnosis and during the follow-up of patients affected by hairy cell leukemia 8
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients 8
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 8
Response to Wirostko et al. Re: "Cross-Linked Hyaluronic Acid as Tear Film Substitute" by Posarelli et al. (J Ocul Pharmacol Ther 2019;35(7):381-387) 8
ErbB in NSCLC as a molecular target: Current evidences and future directions 8
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors 8
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients 8
Prediction of fluoropyrimidine toxicities by screening DPYD genetic variants 8
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials 8
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours 8
Radiomics and liquid biopsy in oncology: the holons of systems medicine 8
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 7
Pharmacodynamics of current and emerging PD-1 and PD-L1 inhibitors for the treatment of non-small cell lung cancer 7
Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment 7
Nicotine Metabolite Ratio in Smokers: A Real World Experience 7
Liquid biopsies from pleural effusions and plasma from patients with malignant pleural mesothelioma: A feasibility study 7
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase 7
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer 7
Recent advances in epigenomics in NSCLC: Real-time detection and therapeutic implications 7
DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer 7
Pharmacokinetic and pharmacogenetic predictive markers of irinotecan activity and toxicity 7
Crizotinib resensitization by compound mutation 7
Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer 7
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool 7
Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines 7
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients 7
Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight 7
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report 7
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 7
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells 7
Understanding EGFR heterogeneity in lung cancer 7
Author's reply. The detection of AR-V7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients 7
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients 7
Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers 7
Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer 6
Totale 892
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.642
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.169 0 0 0 44 19 50 69 149 168 33 309 328
2025/2026171 171 0 0 0 0 0 0 0 0 0 0 0
Totale 1.340